Effects of Early Oral Diet After Cardiac Surgery: an Open Label Randomized Controlled Trial

February 8, 2024 updated by: Hamad Medical Corporation

This is an open label randomized controlled trial with two parallel groups to compare the effects of early initiation of oral diet to reduce the post-operative fasting time in adult patients undergoing cardiac surgery.Primary Objectives:

  • To assess the impact of early and conventional diet on post-operative nausea and vomiting by calculating the simplified PONV (post-operative nausea and vomiting) impact score of patients after cardiac surgery, with a score >5 indicating clinically significant PONV.
  • To study the impact of early versus conventional diet on gastrointestinal function by estimating the difference in timing of the first bowel movement in patients following cardiac surgery.

Secondary Objectives:

  • To evaluate the effects of early versus conventional diet resumption on length of ICU stay among the patients following cardiac surgery in days.
  • To compare the satisfaction levels of patients by visual analogue scale who resumed their oral diets early versus conventionally following cardiac surgery. The estimated sample size of 196 patients with routine post operative recovery after cardiac surgery will be randomized into early (interventional) and late (control) diet groups. Researchers will compare the early diet group with late diet group to see the effects.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This is an open label randomized controlled trial with two parallel groups to compare the effects of early initiation of oral diet to reduce the post-operative fasting time in adult patients undergoing cardiac surgery. Assuming a incidence rate of post-operative nausea and vomiting of 40% in cardiac surgery (Sawatzky et al., 2014), and an anticipated incidence of clinically significant PONV using the simplified PONV impact scale of 20% (Myles et al., 2012), with a presumed 50% risk reduction with early feeding, a power of 80%, and alpha of 0.05, the minimum effective sample size would be 164 subjects (82 per arm). Assuming a drop out of 20%, the sample size was increased to 196 subjects (98 per arm).

Adult patients' status post-operative cardiac surgery in CTICU of Heart Hospital, after extubation, meeting inclusion criteria will be included in the study.

They will be divided into early and conventional diet groups. and randomized using web-based randomization to early diet (intervention arm) versus conventional diet (control arm) in 1:1 ratio. The patients of early group will be examined for water swallowing test (WST) at bedside after extubation. Before performing the WST, the patient must be evaluated for readiness including Awake, alert, cooperative, able to follow command, vital signs are stable, able to maintain at least 75-degree.

in upright position, the patient can cough effectively, the patient can stick out tongue and move to the left and right, the patient can breathe comfortable.

The patient's mouth will be cleaned, and the patient will be asked to drink each 5 ml of water (1 teaspoon) 3 times respectively. If the patient shows any abnormal signs, the test will be discontinued. If all steps are passed, then the patient will continue to drink the entire 90 ml of water from a cup or with a straw in sequential slowly and steadily swallowing without stopping (cup or straw can be held by clinician or patient). (Phothikun N, 2022).

If the patient fails in water swallow test, early diet will not be resumed. The finding will be intimated to the physician in charge of the patient for further management.

For the early group if they pass water swallow test oral diet will be resumed after 2 hours of extubation with water, followed by clear liquid diet after 4 hours and gradually laddered to solid diet as patient prefers/tolerates. For the conventional diet group, the existing standard feeding protocol will be followed, that is patient will be given only sips of water on the day of surgery and the diet will be resumed on the next day after surgery.

The simplified post-operative nausea -vomiting impact score every 4th hourly for 24 hours, time of first bowel movement, the length of ICU stays in days and patient satisfaction level about timing of resuming oral diet using Visual analogue scale at the time of discharge from hospital (VAS) (Appendix 3) will be collected. Participants will be provided with VAS with a statement explaining what the scale was intended to measure that is the level of satisfaction on resuming diet early. Other signs of regaining gut functions like bowel sounds and flatus is not considered in this study because assessment of bowel sounds is not a reliable sign of gut function (Deane et.al,2021) and chances for ambiguity are high while the assessment of bowel sounds. Most of the patients after major surgery with general anaesthesia may not recognize the first flatus in immediate post-operative period. For the patient who is not tolerating the oral diet resumption with any signs of aspiration or clinically significant vomiting or paralytic ileus or patient dissatisfaction with oral diet resumption, early diet trial will be discontinued and reported accordingly.

The study will be conducted at a single center and the patients will be followed for 5 days after surgery. The favorable circumstances enhance safety of early resumption of oral diet in adult cardiac surgery are as follows. The short acting Propofol is used as the major sedation after surgery to prevent prolonged sedative effect. Multimodal analgesia is used to reduce the use of narcotics. Patient controlled analgesia of low dose morphine or fentanyl is used along with intravenous paracetamol and non-pharmacological interventions like massage, changing positions and early mobilization out of bed. Sedation score is assessed every hour by the intensive care nurses using Ramsay Sedation scale. All patients are routinely placed on intravenous metoclopramide injections as prokinetic and antiemetic which may help to enhance peristalsis. Patients are also given oral mucosal massage with flavored glycerin swab sticks to enhance their appetite.

All data will be analyzed using SPSS 24.0 statistical package. Descriptive statistics will be used to describe and compare socio-demographic data on participants between the intervention and control group. Continuous variables that follow a normal distribution will be expressed as means and standard deviations, whereas categorical variables will be presented as frequency counts and percentages. We will estimate simplified PONV (post-operative nausea vomiting) impact score for early and conventional diet groups. Quantitative data between the intervention and control groups will be analyzed using unpaired t or Mann Whitney U test as appropriate. Categorical data will be summarized using frequencies and proportions. Associations between two or more qualitative data variables will be assessed using Chi-square (χ2) test or Fisher Exact test as appropriate. Univariate and multiple regression analysis will be used to control and adjust for potential predictors and confounders such as type of age, gender, nationality and presence of comorbidities and motion sickness. Generalized estimating equation will be used to see the change over the post-operative nausea- vomiting impact score in both the groups over 24 hours. All tests will be two sided and p value considered <0.05 as significant.

No adverse events are expected in either of the groups. Any accidental adverse event will be reported immediately to the physician and the details of the event, harm and treatments will be notified to MRC. And the instructions by MRC will be followed. A record of such events will be maintained for further reference. This is to state that this study will be conducted in full conformance with principles of the "Declaration of Helsinki", Good Clinical Practice (GCP) and within the laws and regulations of MoPH in Qatar. The participants will be able to withdraw from the study anytime without any liabilities during the research process.

Study Type

Interventional

Enrollment (Estimated)

196

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Qatar
      • Doha, Qatar, 3050
        • Recruiting
        • Heart Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients' post-operative status,
  • Post extubation (usually extubated within 4-6 hours after surgery) without any cognitive deficits, expected
  • Minimal chest drain (<100 ml/h), with
  • Awake, alert, oriented without any cognitive impairment
  • Able to pass water swallow test will be included in the study.

Exclusion Criteria

  • Major complicated cardiac surgeries (aortic dissection, surgeries involving mechanical circulatory support (ECMO or Ventricular assist devices).
  • Patients with profuse surgical /chest drain bleeding >100 ml/h for 3 consecutive hours in chest drain,
  • Patients undergo re-exploration sternotomy, cardiac tamponade and
  • Patients with cognitive impairment, drowsy
  • Absence of vocalization after extubation
  • Patients who fails in water swallow test for dysphagia after extubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early diet
The patients of early group will be performed water swallowing test at bedside after 2 hours of extubation. Before performing the Water Swallow Test, the patient must be evaluated for readiness.This interventional group of patients will be initiated with sips of water (warm or cold as patient prefers) at 2 hours of extubation (post-operative day 0) followed by clear liquid diet (tea, clear juice/ soup, gelatin) at 4 hours. If well tolerated, then slowly progress to a full liquid and solid diet as the patient preferred pace.
Dietary supplement: Early diet resumption
Resuming oral diet at pace started from 2 hours after extubation from ventilator.
No Intervention: Conventional diet
Patients in this group will receive the existing standard (conventional) post-operative diet regimen that is sips of water on the day of surgery and initiation of solid oral diet on next day (post-operative day 1)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
simplified post operative nausea vomiting impact score.
Time Frame: 24 hours
To assess the impact of early and conventional diet on post-operative nausea and vomiting by calculating the simplified PONV (post-operative nausea and vomiting) impact score of patients after cardiac surgery, with a score >5 indicating clinically significant PONV.
24 hours
Timing of bowel movements
Time Frame: 5 days
To study the impact of early versus conventional diet on gastrointestinal function by estimating the difference in timing of the first bowel movement in patients of both groups following cardiac surgery.
5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
length of ICU stays in days.
Time Frame: 5 days
To evaluate the effects of early versus conventional diet resumption on length of ICU stay among the patients following cardiac surgery in days.
5 days
patient satisfaction
Time Frame: 2 days

To compare the satisfaction levels of patients by visual analogue scale who resumed their oral diets early versus conventionally. Visual analogue scale scores range from 1 to 5 where 1 indicates extremely dissatisfied with early diet resumption and 5 indicates extremely satisfied.

following cardiac surgery
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hamad Medical Corporation

Investigators

  • Principal Investigator: Siddiha P Shahulhameed, Hamad Medical Corporation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

November 19, 2023

First Submitted That Met QC Criteria

November 19, 2023

First Posted (Actual)

November 24, 2023

Study Record Updates

Last Update Posted (Estimated)

February 9, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MRC-01-23-507

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adult Cardiac Surgery

Clinical Trials on Early diet resumption

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe